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Cancer is one of the leading causes of death worldwide, and affects roughly 1.5 million 
new people in the United States every year.  One of the leading tools in the detection and 
treatment of cancer is radiation.  Tumors can be detected and identified using computed 
tomography (CT) or positron emission tomography (PET) scans, and can then be treated 
with external beam radiotherapy or brachytherapy.  By taking advantage of the physical 
properties of gold and the biological properties of nanoparticles, gold nanoparticles 
(GNPs) can be used to improve both cancer radiotherapy and imaging.  By infusing a 
tumor with GNPs, either using passive extravasation of nanoparticles by the tumor 
vasculature or active targeting of antibody-conjugated nanoparticles to a specific tumor 
marker, the higher photon interaction cross-section of gold will cause more radiation dose 
to be deposited in the tumor during photon-based radiotherapy.  In principle, this would 
allow escalation of dose to the tumor while not increasing the dose to normal healthy 
tissue.  Additionally, if a tumor infused with GNPs was irradiated by an external kilo-
voltage source, the fluorescence emitted by the gold atoms would allow one to localize 
and quantify the GNP concentration.   
 
This work had two main aims: to quantify the GNP-mediated dose enhancement during 
gold nanoparticle-aided radiation therapy (GNRT) on a nanometer scale, and to develop a 
refined imaging modality capable of quantifying GNP location and concentration within 
a small-animal-sized object.  In order to quantify the GNP-mediated dose enhancement 
xii 
on a nanometer scale, a computational model was developed.  This model combines both 
large-scale and small-scale calculations in order to accurately determine the 
heterogeneous dose enhancement pattern due to GNPs.  The secondary electron spectra 
were calculated using a condensed history Monte Carlo code, which is able to accurately 
take into account changes in beam quality throughout the tumor and calculate the average 
energy spectrum of the secondary charged particles created.  Then, the dose distributions 
due to these electron spectra were calculated on a nanometer scale using an event-by-
event Monte Carlo code.   
 
The second aim was to develop an imaging system capable of reconstructing a 
tomographic image of GNP location and concentration in a small animal-sized object by 
capturing gold fluorescence photons emitted during irradiation of the object by an 
external beam.  This would not only allow for localization of GNPs during GNRT, but 
also facilitate the use of GNPs as imaging agents for drug-delivery or other similar 
studies.  It has been shown that a benchtop system utilizing a pencil beam of 
polychromatic x-rays is capable of generating this kind of image.  In theory, using a 
cone-beam x-ray source would allow for extensive parallelization of data collection and 
decreasing scanning time. Thus, the specific aim of the current study was to develop a 
cone-beam implementation of x-ray fluorescence computed tomography (XFCT) that 
meets realistic constrains on image resolution, detection limit, scan time, and dose.  A 
Monte Carlo model of this imaging geometry was developed and used to test the methods 
of data acquisition and image reconstruction.  The results of this study were then used to 







1.1 – Cancer and Gold Nanoparticles 
Cancer is one of the leading causes of death worldwide and affects roughly 1.5 million 
new people in the United States every year.  One of the leading tools in the detection and 
treatment of cancer is radiation.  Tumors can be detected and identified using Computed 
Tomography (CT) or Positron Emission Tomography (PET) scans, and can then be 
treated with external beam radiotherapy or brachytherapy.  By taking advantage of the 
physical properties of gold and the biological properties of nanoparticles, gold 
nanoparticles (GNPs) can be used to improve both cancer radiotherapy and imaging. 
 
GNPs are an attractive option for these applications due to both the chemical properties 
of gold and the tumor specificity of properly-sized nanoparticles. Gold is chemically 
inert, biologically non-reactive, and molecularly stable.  Nanoparticle specificity to the 
tumor can be accomplished simply by “passive” targeting, which relies on the leaky 
vasculature of tumors.1  Through a phenomenon known as “Enhanced Permeability and 
Retention (EPR),”2 GNPs of sufficiently small size are able to penetrate the tumor 
vasculature and interstitium, resulting in an elevated concentration of nanoparticles in the 
tumor as compared to that of normal tissue. In addition, nanoparticles can be conjugated 
to an array of tumor-specific biomarkers under an “active” targeting scenario.  These 
potential targets include tumor markers such as epidermal growth factor receptor 
2 
(EGFR)3 and human epidermal growth factor receptor-2 (HER2),4 and mediators of 
angiogenesis such as vascular endothelial growth factor (VEGF).5 Whereas antibody 
conjugation would localize the nanoparticles to the surface of cancerous cells, other 
biomarkers could concentrate the nanoparticles inside the cells. For instance, 
deoxyglucose could bring gold nanoparticles into metabolically active cells via a 
mechanism similar to fluorine-18 deoxyglucose positron emission tomography (FDG-
PET) imaging.6 
 
By infusing a tumor with GNPs, either using passive extravasation of nanoparticles by 
the tumor vasculature or active targeting of antibody-conjugated nanoparticles to a 
specific tumor marker, the higher photon cross-section of gold will cause more radiation 
dose to be deposited in the tumor during photon-based radiotherapy.  In principle, this 
would allow escalation of dose to the tumor while not increasing the dose to normal 
healthy tissue.  Additionally, if a tumor infused with GNPs was irradiated by an external 
kilo-voltage source, the fluorescence emitted by the gold atoms would allow one to 
localize and quantify the GNP concentration.   
 
1.2 – Gold Nanoparticle-aided Radiation Therapy 
Mechanisms of Interaction Enhancement 
Photon-based radiation therapy relies on the energy deposition within a tumor by 
secondary electrons created due to various physical interactions between photons and 
tumor tissue. Most advances in photon-based radiation therapy have been made through 
modifications to the radiation treatment field, either by modifying the radiation quality of 
3 
sources (such as increasing beam energy to MV range) or by improving the conformity of 
the photon beam to the tumor (such as 3D Conformal Radiotherapy, Intensity Modulated 
Radiation Therapy, Arc Therapy). However, by adjusting the photon interaction 
probabilities of tumor, it would be possible to selectively increase the tumor dose during 












Z                                                            Eq. 1.2.1 
 
Equation 1.2.1 shows the proportionality among the photoelectric mass attenuation 
coefficient, , the atomic number of the interaction medium, Z, and the energy of the 
incoming photon, h. The probability of photoelectric interactions increases as the third 
power of Z, and decreases as the third power of the energy.  In principle, since the 
probability of photoelectric absorption drastically increases with the atomic number (Z) 
of the medium, infusion of the tumor with any high Z substance during photon irradiation 
would result in a greater fraction of the incident photon energy being imparted without 
escalation of damage to the surrounding healthy tissue.  Figure 1.2.1 (adapted from Ref. 
20) shows the amount by which the attenuation coefficient of tissue is increased with the 
addition of small amounts of gold, and it can be seen that there is a significant increase in 






























ICRU tissue with 2 mg Au / gram
ICRU tissue with 7 mg Au / gram 
ICRU tissue with 18 mg Au / gram
 
Figure 1.2.1: Increase in attenuation coefficient due to the addition of small 
concentrations of gold to tissue (Adapted from Ref. 20).  
 
Contrast-Enhanced Radiation Therapy 
Researchers have examined several methods of radiosensitization/dose enhancement 
using high-Z materials, focusing mainly on iodine or other similar CT contrast agents 
during kilo-/mega-voltage irradiation.7-14 Iodine (Z=53) is a widely used contrast agent 
for CT due to the same principles described above: namely, increased photon absorption 
due to the Z3 dependence of the photoelectric cross section.  Materials with high iodine 
content can be injected intravenously into a patient, and the restriction of these 
compounds to the circulatory system or other organs can create contrast in the resulting 
image where there may not be any noticeable material difference otherwise.  This is an 
especially powerful tool for imaging blood vessels.  However, it was seen in dose 
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measurements during imaging with contrast agents that the increased interaction 
probability was resulting in increases to the dose deposited during imaging.15 
 
This mechanism forms the basis of a method of radiotherapy dose enhancement known as 
Contrast Enhanced Radiation Therapy (CERT).  In this technique, the therapeutic dose of 
x-rays delivered to an object is increased in regions of higher iodine content.  It was seen 
that CERT using iodine was capable of enhancing dose deposition during in-vitro 
treatment using 20-110 keV (effective) beams by as much as a factor of 3 at iodine 
concentrations of 5% by volume.7  This study also reported a significant increase in 
tumor regression in mice by using intratumoral injection of iodine followed by irradiation 
by 100 kVp x-rays, as compared to x-ray therapy alone.  These results were confirmed by 
subsequent in vitro8 and in vivo9 studies. 
 
Gold Nanoparticle-aided Radiation Therapy 
An approach utilizing GNPs has the potential to be more effective than previous 
approaches due to both the higher Z of gold and the greater tumor specificity of properly-
sized nanoparticles. For example, an animal study demonstrated that mice irradiated with 
250 kVp x-rays after intravenous injection of GNPs demonstrated remarkable tumor 
regression and long-term survival compared to mice irradiated without gold present.16-17  
Additionally, it has been demonstrated that gold nanoparticle-aided radiation therapy 
(GNRT) can be more effective at treating traditionally radio-resistant tumors such as 
squamous cell carcinoma in mice.18  These encouraging outcomes could be attributed to 
the dose enhancement to the tumor and tumor vasculature due to GNPs and kilovoltage x-
6 
rays. The dose enhancement due to GNPs and various photon sources was quantified by a 
subsequent Monte Carlo19-20 study, and demonstrated that the macroscopic dose 
enhancement (shown in Figure 1.2.2, adapted from Ref. 20) depended on both the gold 
concentration and photon beam quality. Additionally, it was shown that this enhancement 
had the potential to exceed several hundred percent for lower energy sources.19  Some of 
these results were independently confirmed by a non-Monte Carlo theoretical study based 













Yb-169 & 7 mg Au
Yb-169 & 18 mg Au
Yb-169 & 7 mg Au + 2 mg Au
Ir-192 & 7 mg Au
Ir-192 & 18 mg Au
Ir-192 & 30 mg Au
tumor tissue
 
Figure 1.2.2: Macroscopic Dose Enhancement Factor (MDEF) for tumors loaded with 
0.7%-3.0% Au by weight under irradiation by 169Yb and 192Ir (Adapted from Ref. 20). 
MDEF represents the amount by which the macroscopic dose is enhanced by the addition 
of GNPs, and is equal to the ratio of the dose during irradiation in the presence/absence 
of GNPs.   
 
In a recent Monte Carlo study, it has also been shown that gold enhances dose to a tumor 
through an increase in the amount of photoelectric absorption, which can lead to an 
7 
increase of up to two orders of magnitude in the number of photoelectrons and 
Auger/Coster-Kronig electrons produced, depending on the energy spectra of photon 
sources.20  Figure 1.2.2 (adapted from Ref. 20) shows that macroscopic dose 
enhancement (MDEF) seen in this study was as high as 100% for 192Ir and 169Yb photons 
sources irradiating tumors loaded with 0.7%-3.0% Au by weight.  Due to these spectral 
considerations, it is important to carefully choose the photon source spectrum to 
maximize the fraction of photoelectric absorptions. Brachytherapy is well-suited to 
GNRT, as typical radionuclide seed sources such as 125I, 103Pd, and 192Ir emit photons 
primarily in the keV range.  Photoelectric absorption can be enhanced further by selecting 
a source with a preponderance of photons just above the absorption edges of gold.  For 
example, 169Yb has an intensity-weighted average energy of about 93 keV,22 just 
exceeding the gold K-edge of 80.7 keV.  
 
While it has been demonstrated computationally that GNPs can enhance the dose during 
brachytherapy by up to about 70% macroscopically20 (or on average across the tumor) at 
a tumor gold concentration deemed achievable in vivo16 (i.e., 7 mg per g tumor after an 
intravenous injection of 1.9 nm diameter GNPs), it is not known exactly how a 
nanoparticle influences the dose on a nanometer or cellular scale.  Due to the short ranges 
of 10-100 keV electrons, it is likely that the dose due to secondary electrons from GNPs 
may be concentrated in the vicinity of GNPs themselves, leading to an even more 
dramatic increase in the dose to nearby tumor cells. Consequently, it is reasonable to 
argue radiobiological outcomes (e.g., radiosensitization) from GNRT could be better 
correlated with the dose enhancement estimated microscopically on a nano-/cellular-scale 
8 
than that estimated macroscopically. Moreover, the spatial variation of microscopic dose 
enhancement could be crucial in deciding between passive or active nanoparticle 
targeting scenarios.   
 
Unfortunately, current macroscopic dose estimation methods19-20 which rely on 
condensed history Monte Carlo calculations are unable to accurately determine the 
localized enhancement of radiation dose on the small scale (nm - m), as the typical 
electron step size of these codes is on the order of millimeters.  Additionally, as the dose-
enhancement process is dominated by low-energy (1-10 keV) Auger/photo-electrons, 
condensed history codes have some difficulty in accurately determining the spatial 
distribution of dose deposition of these short-ranged electrons.  Therefore, it is necessary 
to utilize an approach which can perform these small scale calculations, such as an event-
by-event Monte Carlo technique.  
 
1.3 – X-Ray Fluorescence Computed Tomography for GNP Localization 
Emission tomography has a long history of successful application in the field of 
radiology.  In general, this technique involves generating a tomographic image of activity 
inside an object by detecting radiation emitted by the substance in question.  Typically, 
the substance is a radioisotope which emits either a single photon (Single Photon 
Emission Tomography, SPECT) or a positron, which annihilates and emits two photons 
(Positron Emission Tomography, PET).  This imaging modality hinges on the successful 
detection of radiation that is specific to the radioisotope, such as the 140-keV photon in 
99mTc SPECT or the dual 511-keV annihilation photons in PET.  An image can also be 
9 
reconstructed by capturing photons stimulated by irradiation with an external beam of 
radiation, instead of injection radioactivity directly.  Such imaging modalities can be 
called Stimulated Emission Tomography.  For instance, it is possible to verify dose 
delivery in proton radiotherapy by performing PET imaging to detect 11C and 15O 
produced during interactions of protons with tissue.23 This principle of Stimulated 
Emission Tomography forms the basis of X-Ray Fluorescence Computed Tomography 
(XFCT), which involves the detection of characteristic fluorescence x-rays emitted by an 
object under irradiation by an external x-ray beam.   
 
Within the last decade, some notable applications utilizing GNPs have emerged for 
cancer imaging 6, 24-27, radiation therapy 16-20, 28, and thermal therapy 29-32.  While the 
development of these applications relies on animal studies, previous research effort was 
often hindered or delayed by some research challenges inadequately addressed. One such 
challenge appears to be the lack of an effective in-vivo assay or imaging tool to determine 
the biodistribution of GNPs injected into animals. Without such a tool, the biodistribution 
of GNPs needs to be determined via ex-vivo analysis after sacrificing animals. In 
principle, it would be possible to determine the biodistribution of GNPs in vivo if the 
spatial distribution and amount of GNPs within a tumor and other critical organs can be 
quantified by imaging a live animal injected with GNPs. 
 
In order to calculate the amount of dose enhancement that would occur during GNRT, 
one must be able to quantify the amount of GNPs within a tumor or other critical organs 
in vivo.  Since gold is a high atomic number substance (Z=79), and its K-Shell 
10 
fluorescence (~65 keV) is able to escape a small animal-sized object, XFCT is a 
promising approach to addressing these imaging challenges.  XFCT is typically 
performed using monochromatic x-rays, such as those from a synchrotron, to take 
advantage of photoelectric edge absorption in the interrogated material.33-36  This method 
has been used to quantify the distribution of substances within a homogeneous medium37 
as well as iodine within a thyroid sample.38 However, this technique does not lend itself 
to in-vivo imaging due to high dose rate and limited access of synchrotron beams.  
Therefore, it would be advantageous to develop a benchtop XFCT system capable of 
measuring the distribution and concentration of GNPs in vivo. 
 
There are a handful of existing imaging techniques which may be able to meet the 
technical criteria above.  Optical spectroscopy has been found feasible for quantification 
of nanoparticle concentration in vivo.26, 39  GNPs may also be detected in certain x-ray 
computed tomography (CT) imaging situations, similar to Iodine contrast.25  There are 
also several emerging imaging modalities which may prove capable of locating gold 
nanoparticles in organs, such as dual energy CT40 and K-edge x-ray CT.41 However, it is 
not known whether these newer techniques will have the sensitivity required to detect 
biologically relevant concentrations of GNPs.  To our knowledge, no single imaging 
modality apart from XFCT is able to simultaneously determine both the distribution and 
concentration of GNPs in vivo.  Recently, XFCT has been shown to be feasible using a 
110 kVp polychromatic, pencil-beam source.42 This technique was used to generate an 
image of the spatial distribution and concentration of GNP-loaded regions in a 5-cm-
11 
diameter plastic phantom.  However, this technique requires refinement for in vivo 
applications due to excessive dose and prolonged scan time.   
   
 
1.4 – GNRT and XFCT: Aims of Current Work 
 
While GNRT and XFCT are already very powerful tools for radiation-based treatment 
and imaging, they could be made more powerful with further refinement.  Investigations 
into the mechanisms of dose enhancement for GNRT are currently based on large scale, 
macroscopic calculations of radiation dose enhancement.19-20  Additionally, tools to 
quantify heterogeneous dose enhancement patterns for GNRT must be based on the 
distributions and concentration of GNPs within the tumor, which currently require 
synchrotron-based non-destructive analysis or ex vivo analysis after the sacrifice of live 
animals.    Therefore, this work had two main aims: to quantify the GNP-mediated dose 
enhancement during GNRT on a nanometer scale, and to develop a refined imaging 
modality capable of quantifying GNP location and concentration within a small-animal-
sized object.   
 
First, in order to quantify the GNP-mediated dose enhancement on a nanometer scale, a 
computational model was developed.  In this model, the spectrum of secondary electrons 
emitted by gold and water under irradiation with different photon sources was determined 
by Monte Carlo methods.  Then, event-by-event Monte Carlo transport of these electrons 
was used to calculate the resulting dose from a hypothetical nanoparticle of gold or water.  
12 
This model combined both large-scale and small-scale calculations in order to accurately 
determine the heterogeneous dose enhancement pattern due to GNPs.  The secondary 
electron spectra were calculated using a condensed history Monte Carlo code, which is 
able to accurately take into account changes in beam quality throughout the tumor and 
calculate the average energy spectrum of the secondary charged particles created.  Then, 
the dose distributions due to these electron spectra were calculated on a nanometer scale 
using an event-by-event Monte Carlo code. 
 
The second aim was to develop an imaging system capable of reconstructing a 
tomographic image of GNP location and concentration in a small animal-sized object by 
capturing gold fluorescence photons emitted during irradiation of the object by an 
external beam.  This would not only allow for localization of GNPs during GNRT, but 
also facilitate the use of GNPs as imaging agents for drug-delivery or other similar 
studies.  It has been shown that a benchtop system utilizing a pencil beam of 
polychromatic x-rays is capable of generating this kind of image.42  In theory, using a 
cone-beam x-ray source would allow for extensive parallelization of data collection and 
decreasing scanning time.  Thus, the specific aim of this study was to develop a cone-
beam implementation of XFCT that meets realistic constrains on image resolution, 
detection limit, scan time, and dose.  A Monte Carlo model of this imaging geometry was 
developed and used to test the methods of data acquisition and image reconstruction.  The 
results of this study were then used to drive the production of a functioning benchtop, 




GOLD NANOPARTICLE-AIDED RADIATION THERAPY 
 
 
2.1 – Introduction 
Traditionally, methods to calculate the dose enhancement during photon-based 
radiotherapy due to gold nanoparticles (GNPs) have centered around macroscopic 
approaches.19-20    These approaches are reasonable, as they constitute a direct test of the 
effect of GNPs.  Using Monte Carlo methods, dose is recorded in a volume before and 
after the addition of GNPs, and the ratio of these two doses is the factor by which GNPs 
enhanced dose deposition.  While this generates an accurate model of the macroscopic 
effects of GNPs, this approach is insufficient for three reasons.  First, the nanoparticles 
are by definition small, even when compared to cells.  Sizes of GNPs can range from 120 
nm43 to as small as 1.9 nm.16    Second, dose is enhanced during GNRT primarily through 
the photoelectric effect and subsequent Auger emission,20 and the range of these electrons 
is also small on cellular scales.  For instance, the range of 10-50 keV electrons in water is 
2.5 m to 43 m.44  Third, the distribution of GNPs in vivo can be very heterogeneous.30  
Taken together, this would indicate that it may not be sufficient to assume a 
homogeneous pattern of dose enhancement, but rather that the enhancement may be 
concentrated within a few microns of the GNPs and that the overall enhancement is 
strongly dependent on the distribution of GNPs in vivo.   
 
14 
In this study, a three-step approach is taken in order to calculate the dose enhancement 
due to GNPs on a micro-/nano-meter scale.  It is similar to the kernel-based approach 
taken in many radiotherapy dose calculation algorithms, where the directional dose kernel 
of electrons is convolved with the distribution of photon interactions in tissue.  Consider 
the scanning electron microscopy (SEM) image shown in Figure 2.1.1, showing GNPs 
(gold nanoshells to be precise) appeared as white spots in tissue.  Conventional 
condensed history Monte Carlo technique is unable to calculate the dose enhancement in 
this case directly, as the typical electron step size on the order of mm far exceeds the 
problem domain.  However, the dose due to this heterogeneous distribution of GNPs 
could be calculated if the point dose kernel of a GNP was known.  This point dose kernel 




Figure 2.1.1: SEM image of gold nanoshells (appearing as white dots) in tissue.30 
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The steps of this nanoscale dose calculation are as follows.  First, the spectrum of 
secondary electrons generated by gold and water during photon irradiation of a GNP-
loaded water phantom is calculated using large-scale Monte Carlo calculations.  These 
simulations determine, on average, the energy spectrum of secondary electrons, and take 
into account changes in the photon spectrum throughout the phantom.  The second step is 
to calculate the point dose kernel of these electron spectra.  Finally, these kernels are 
applied to the SEM image in Figure 2.0.1 in order to determine the effect of GNPs. 
 
2.2 - Updates to Point Dose Kernels and Microscopic Dose 
The aforementioned method for nanoscale dose calculations was first reported in a 
previous publication.45  The spectrum of secondary electrons from atoms of gold and 
molecules of water resulting from irradiation by common photon sources (125I, 103Pd, 
169Yb, 192Ir, 6 MV, 50 kV) have been reproduced in Appendix A for the sake of 
completeness. The calculations of the point dose kernels, microscopic dose enhancement 
factor, and microscopic dose enhancement to the sample SEM image have been 
improved, and the results presented in this publication are considered to be more 
accurate.  Specifically, event-by-event Monte Carlo calculations using the NOREC code 
at locations very near the GNP have been improved, resulting in a more accurate 
estimation of the sub-micron point dose kernel.  Additionally, the calculation of scaling 
factors for gold/water dose was also improved.  To verify the methods used, 




2.3 - Electron Point Dose Kernels 
In order to determine the microscopic dose distribution due to secondary electrons, an 
event-by-event (or detailed history) electron Monte Carlo code NOREC46 was used. To 
obtain accurate results on a nanometer scale, it was important to utilize an event-by-event 
code rather than a condensed history code due to the fact that the intended spatial 
resolution of the dose distribution (< 1 m) is much smaller than the typical electron step 
size used for condensed history codes such as EGSnrc or MCNP. The NOREC code has 
been benchmarked well against several other common condensed history Monte Carlo 
codes including EGS4 and ETRAN on a larger scale.47-48 Accordingly, NOREC is 
expected to produce reliable results on a nanometer scale as well by virtue of its event-
by-event electron transport algorithm, although calculated results on such a small scale 
are difficult to verify experimentally. NOREC is implemented as a C++ class which 
performs event-by-event transport of electrons in water for the energy range from 7.4 eV 
to 1 MeV. The effects of this energy limitation on sources with higher energy 
components such as 103Pd and 6 MV x-ray are addressed during the presentation of the 
results. More details about NOREC can be found elsewhere.46-47  
 
Benchmarking of NOREC Code 
The current NOREC implementation was benchmarked against published values for dose 
kernels of monoenergetic eletrons.47  The results of these benchmarks are shown in 
Figures 2.3.1-2.  These figures show the scaled point dose kernels of 20 keV and 1 MeV 
electrons as a function of the r0, the CSDA range.  There were minor differences in some 
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parameters of the two dose kernel studies, such as the thickness of the dose scoring shell, 
location of the dose scoring shell, and number of histories; however, there is good 
agreement in the results.  The current NOREC implementation was also benchmarked 
against the EDKnrc code.49  For this simulation, two polyenergetic secondary electron 
spectra were used; namely, 169Yb and 6 MV.  Unlike the monoenergetic spectra, these 
dose kernels decrease strongly with distance, as the lower energy electrons do not travel 
as far as those with higher energy.  As NOREC is an event-by-event code, it is expected 
that it will have more accurate results for the very short electron ranges considered.  As 
seen in Figure 2.3.3, there is general agreement between the two codes; however, there 
are slight differences in the very low dose regions at an increased distance from the 
source.  This is likely due to the condensed history method used by EGSnrc.   
 
 
Figure 2.3.1: Benchmarking results for NOREC code for monoenergetic 20 keV 
electrons.  The implementation of NOREC used in this work was benchmarked against 




Figure 2.3.2: Benchmarking results for NOREC code for monoenergetic 1 MeV 
electrons.  The implementation of NOREC used in this work was benchmarked against 





Figure 2.3.3: Benchmarking of NOREC code against EDKnrc, the dose kernel module of 
EGSnrc.  These data are shown for two polyenergetic electron spectra resulting from 






To calculate the dose kernels of the secondary electron spectra, NOREC calculations 
were performed by treating each secondary electron spectrum as a point source of 
electrons in an infinite medium of water. The number of histories for these calculations 
ranged from 0.5 to 50 M, depending on the secondary electron spectrum. The energy 
deposition of the electrons was recorded in a set of 100 nm-thick concentric spherical 
shells out to a maximum radial distance of 500 m. The uncertainty in the results was 
estimated by tracking the number of energy deposition events in each shell and 
calculating the Poisson standard deviation of N-1/2.  The uncertainty in each significant 
region (with dose greater than 1% of maximum) in all cases was less than 1%.   
 
In order to compare the dose point kernel results between different cases, several 
corrections were necessary. First, the dose per electron at each radial distance was 
divided by the maximum dose to yield the electron dose point kernel. Also, since 
NOREC simulations for gold and water were performed with the same number of 
electron histories, some corrections were necessary to scale the dose point kernels for 
gold to allow comparison with the water case under an identical photon irradiation 
scenario. The first scaling factor accounted for the different amount of electrons emitted 
by gold and water during spectrum acquisition, and was simply the ratio of the total 
number of electrons emitted by gold and water. The second factor accounted for the 
different concentration of water molecules and gold atoms approximating GNPs in a 
given volume of gold-loaded water medium (i.e. tumor) being irradiated during spectrum 
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acquisition and was a constant value of 142 in the current study, regardless of photon 
sources.  The values of these scaling factors are shown in Table 2.3.1. 
 
            Table 2.3.1: Scaling Factors for Energy Deposition Kernels 





50 kVp 232.4 
6 MV 4.4 
 
 
In order to quantify the effect of GNPs present within the tumor during radiation therapy, 
a comparison was made between the dose due to gold and water scaled dose point 
kernels. The ratio of these two values at a specific radial distance yielded the 
enhancement in dose kernel due to the inclusion of GNPs within the tumor. Considering 
only the dose originating from a single point of water, this number represents the factor 
by which the dose would be increased by replacing that point with a GNP. This 
enhancement in the dose kernel is defined as the microscopic dose enhancement factor 
(mDEF). 
 
Results of NOREC Calculations 
The relative electron dose point kernel for the six photon sources are shown in Figures 
2.3.4-9(a) and is presented as a fraction of the maximum dose deposited at each radial 
distance. The dose point kernel depends strongly on the quality of the secondary electron 
spectrum, as evidenced by the sharp dose fall-off in the lower energy sources (e.g., 103Pd, 
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125I, and 50 kVp) as compared to the higher energy sources. For each source, the dose 
point kernel gives insight into the range of effect of GNPs during treatment. For 103Pd, 
125I, and 50 kVp, it is apparent that GNPs would only significantly affect the region 
within 30-40 m. For 169Yb, the dose point kernel extends beyond 100 m, while for 192Ir 
and 6 MV x-rays the dose kernel extends out beyond the 100 m range.  In the case of 
the 6 MV x-ray dose kernel, NOREC was unable to simulate those secondary electrons 
with energy greater than 1 MeV. This limitation possibly introduced some uncertainty in 
the current dose point kernels for 6 MV x-rays, because the dose contribution from those 
omitted high energy secondary electrons within 500 m radial distance was not properly 
taken into account. On the other hand, the effect of this uncertainty on the estimation of 
mDEF and microscopic dose enhancement for the test case was believed to be small, 
because the contribution of high energy secondary electrons originating from gold and 
water could roughly cancel each other when taking the ratios during the calculations.   
 
The dose point kernel in terms of dose per source photon per GNP, or scaled dose point 
kernel, is shown in Figure 2.3.4-9(b). One can see the benefit of a lower energy source 
spectrum, as the increased contribution of photoelectric absorption in gold creates many 
more secondary electrons per incident photon.  125I, 103Pd, 169Yb, and 50 kVp, all having a 
strong spectral component below the K-edge of gold, show a substantial increase in 
energy deposition within the 50 m range. On the other hand, 169Yb, with an average 
energy very close to the K-edge of gold, shows a large amount of electron energy 




                                      (a)                                                                    (b) 
Figure 2.3.4: 169Yb - (a) Relative Dose Point Kernels and (b) Scaled Dose Point Kernels 
in a water medium for a gold nanoparticle and a hypothetical water nanoparticle under 







                                      (a)                                                                    (b) 
Figure 2.3.5: 125I - (a) Relative Dose Point Kernels and (b) Scaled Dose Point Kernels in 
a water medium for a gold nanoparticle and a hypothetical water nanoparticle under 




                                      (a)                                                                    (b) 
Figure 2.3.6: 103Pd - (a) Relative Dose Point Kernels and (b) Scaled Dose Point Kernels 
in a water medium for a gold nanoparticle and a hypothetical water nanoparticle under 








                                      (a)                                                                    (b) 
Figure 2.3.7: 50 kVp - (a) Relative Dose Point Kernels and (b) Scaled Dose Point 
Kernels in a water medium for a gold nanoparticle and a hypothetical water nanoparticle 




                                      (a)                                                                    (b) 
Figure 2.3.8: 192Ir - (a) Relative Dose Point Kernels and (b) Scaled Dose Point Kernels in 
a water medium for a gold nanoparticle and a hypothetical water nanoparticle under 








                                      (a)                                                                    (b) 
Figure 2.3.9: 6 MV - (a) Relative Dose Point Kernels and (b) Scaled Dose Point Kernels 
in a water medium for a gold nanoparticle and a hypothetical water nanoparticle under 
irradiation by 6 MV.  
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The microscopic dose enhancement factor (mDEF) is graphically shown in Figures 
2.3.10.  These values are only shown out to a radial distance of 100 m, as the energy 
deposition beyond that distance is negligible.  As expected, the mDEF in the area 
immediately surrounding the GNP is quite large, being at least 80 for all cases apart from 
the 6 MV source, which had mDEF values ranging from 1.4-9.8.  As shown in Figure 
2.3.11, the effects of a lower energy source spectrum are again evident, as the 125I, 50 
kVp, 103Pd, and 169Yb spectra show a two order of magnitude mDEF over short distances.  
The intermediate energy source, 169Yb (Figure 2.3.12), has mDEF values exceeding 100 
at a greater range from the GNP location.  The high energy sources, 192Ir and 6 MV 
(Figure 2.3.13) show little mDEF. 
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Figure 2.3.10: Microscopic dose enhancement factor (mDEF) obtained by taking the ratio 




Figure 2.3.11: Low Energy mDEF - Spatial variation of microscopic Dose Enhancement 
Factor (mDEF) around a GNP. mDEF represents the factor by which that the dose would 
be increased by replacing that point with a GNP. The results are shown along the radial 
direction from a hypothetical GNP at the center.  The value shown in each panel is the 




Figure 2.3.12: Intermediate Energy mDEF - Spatial variation of microscopic Dose 
Enhancement Factor (mDEF) around a GNP. 
 
 
Figure 2.3.13: High Energy mDEF - Spatial variation of microscopic Dose Enhancement 






2.4 - Nanometer-Scale Dose Calculations 
To further understand the phenomenon of dose enhancement in GNRT, the dose kernel of 
secondary electrons from GNPs was calculated on a nanometer scale using Monte Carlo 
methods.  It can be seen in Figure 2.3.2 that, even within 1 m from the GNP, the dose 
kernel exhibits a very steep gradient.  Furthermore, nanoparticles anywhere from 2-100 
nm in size may be applied to GNRT.  The target of the radiation dose, DNA, has a width 
of only 2 nm.  Thus, determining the dose kernel on a sub-micron level is necessary to 
fully characterize the dose enhancement process. 
 
In order to calculate the dose on a nanometer-sized grid, several refinements must be 
made to the methods presented in Sections 2.2 and 2.3.  First, the secondary spectrum 
must be recorded in much finer bins, since small changes in energy can have a ~1 nm 
change in the range of secondary electrons.  Second, the energy cutoff for the secondary 
spectrum measurement must be lower than 1 keV, since these electrons can have a 
significant impact on the dose kernel under 1 m.  Third, these methods must be tested 
on a microscopy image of GNPs with a finer spatial resolution in order for the changes to 
be visible. 
 
To that end, these computational methods were applied to the irradiation of a mouse 
using 250 kVp photons.  The EGSnrc geometry was modified in order to replicate the 
treatment scenario; specifically, a 1x1x1 cm3 gold-loaded region protruded from the front 
face of a 30x30x30 cm3 water phantom.  The gold-loaded region contained a mixture of 
water and gold (0.7 % Au by weight), and was irradiated by a 2x2 cm2 250 kVp beam (50 
31 
cm SSD).  The cutoff energy was lowered to 100 eV for photon and electrons, allowing 
the collection of very low energy auger electrons.  The results of these simulations are 
shown in Figure 2.4.1. 
 
 
Figure 2.4.1: Secondary spectrum of electrons for 250 kVp photon source 
 
The dose kernel of these secondary electrons was calculated using the event-by-event 
code NOREC, using the methodology described previously.  In this simulation, the width 
of the dose collection shells was lowered to 1 nm in order to obtain a very fine resolution 
on the dose kernel.  Since the short-range kernel was the focus of this investigation, the 
dose was only collected out to a maximum radial distance of 30 m.  From the secondary 
electron spectra, the gold/water dose scaling factor was calculated to be 54.  This agrees 
well with expectations, as the scaling factors for 169Yb and 192Ir were 84 and 14, 
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respectively.  The mDEF was calculated by taking the ratio of the scaled gold and water 
dose kernels.  The dose kernels are shown in Figure 2.4.2, and the mDEF is shown in 
Figures 2.4.3 and 2.4.4. 
 
Figure 2.4.2: Relative and Scaled dose kernels for 250 kVp secondary electrons 
 






Figure 2.4.4: 250 kVp mDEF - Spatial variation of microscopic Dose Enhancement 
Factor (mDEF) around a GNP. mDEF represents the factor by which that the dose would 
be increased by replacing that point with a GNP. The results are shown along the radial 
direction from a hypothetical GNP at the center.  The value shown in each panel is the 
maximum mDEF for the given source. 
 
 
2.5 - Microscopic Dose Enhancement 
To calculate the microscopic dose enhancement due to the presence of gold, the kernels 
were applied to a scanning electron microscopy (SEM) image of a GNP distribution in 
tissue.30 Each pixel in the image was treated as a point source of either gold or water 
secondary electrons based on the intensity of that pixel, and with the dose point kernels, 
the radial dose distribution around each pixel was calculated. The dose enhancement 
calculation was performed in two steps under the assumption that the GNP distribution in 
three dimensions is similar to that of the two-dimensional image used.  First, the water-
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only dose was calculated for each pixel in the image by summing the dose contribution of 
every other pixel in the image using the dose kernel for water secondary electrons. In the 
second step, the dose contribution of each gold pixel in the image was found for every 
other pixel by adding the difference of the gold and water 2-D radial dose at that distance. 
Finally, the dose collected at each point was divided by the water-only dose to yield the 
factor by which the dose was enhanced at that point by the inclusion of GNPs. Note, 
during the current dose calculations, possible perturbation due to neighboring GNPs (i.e., 
screening effect) was not taken into account. This effect could be pronounced if GNPs 
are severely clustered within tissue and, may need to be investigated in future studies.  
 
The microscopic dose enhancement due to GNPs in the sample SEM image, defined as 
the ratio of dose deposited at each point between the gold and water cases, is shown in 
Figures 2.5.1-4 for the representative sources 169Yb, 50 kVp, and 250 kVp.  The results 
for 192Ir, 103Pd, 125I, and 6 MV are shown in Appendix B.  The 50 kVp and 250 kVp 
sources, which contained the strongest low-energy component, demonstrated a 
microscopic dose enhancement as high as 500-2000% within the tumor vasculature. One 
can also see that the 5% enhancement line extends roughly 10 m from the nanoparticle 
clusters. A greater long-range effect was seen in the 169Yb and 250 kV sources, where the 
5% enhancement line extended upwards of 30 m from the nanoparticle clusters, and the 




Figure 2.5.1: Microscopic Dose Enhancement from 169Yb photon source for the specific 
GNP distribution in vivo obtained from the previous work.32 1.05, 1.10, and 2 represent 





Figure 2.5.2: Microscopic Dose Enhancement from 50 kVp photon source for the specific 







Figure 2.5.3: Microscopic Dose Enhancement from 250 kVp photon source for the 
specific GNP distribution in vivo obtained from the previous work.32  
 
 
Figure 2.5.4: Microscopic Dose Enhancement from various photon source for the specific 
GNP distribution in vivo obtained from the previous work.32  The dose enhancement is 
shown zoomed to the large GNP cluster in the upper part of Fig. 2.4.1-3 
 
Note that, in Figure 2.5.4, the isodose lines were only shown up to a maximum of a factor 
of 20, since any enhancement above this occurred inside the GNPs, and these values were 
considered non-physical as the self-absorption of the gold is expected to be roughly 5% 
for a 250 kVp source.50   
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2.6 - Discussion 
It has been shown previously that the macroscopic dose enhancement for 125I, 169Yb, and 
50 kVp ranged from 50% to 100% at a uniform gold concentration of 7 mg Au/g tumor.20 
The current study demonstrates that the microscopic dose around a GNP is enhanced by 
factors up to more than 100, and the microscopic dose within a tumor is enhanced by 
over 100% over short distances for a test case based on a realistic (i.e., non-uniform) gold 
nanoparticle distribution in tissue. Although performed under somewhat different 
conditions, the current computational study strongly supports a finding from a previous 
experimental study with diagnostic x-rays that reported a similar level of dose 
enhancement (i.e., a factor of 100) on a cellular level due to the presence of gold (i.e. 
gold foil).51 Moreover, it shows significant variation in microscopic dose enhancement 
between the different source cases. This variation could be exploited to allow for tailoring 
of the source to the spatial distribution of GNPs in vivo. For instance, 125I or 50 kVp 
would result in large increases in the radiobiological effectiveness if GNPs can be 
brought within sufficient distance of the targeted cells. On the other hand, irradiation 
using a 169Yb source leads to a meaningful dose increase over a larger distance, and could 
still be effective given a more heterogeneous spatial distribution of GNPs. The 250 kVp 
source shows even greater promise for microscopic dose enhancement.  In Figures 2.5.3-
4, the microscopic dose is enhanced by 10% at distances of 30-40 m from the GNP 
clusters, and by over 2000% at sub-micron distances.   
 
In general, it can be seen that there is very significant ( >100%)  dose enhancement with 
GNPs for a wide range of photon sources.  However, it is seen that this extreme 
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enhancement is confined to the region within roughly 5 m of the GNPs.  Previous 
studies indicate that untargeted nanoparticles tend to remained trapped in the perivascular 
space within tumors, but targeted nanoparticles have the potential to penetrate the tumor 
interstitium and bind directly to tumor cells.27 Given the short range of GNP secondary 
electrons, it can be expected that the maximum radiobiological benefit (killing of tumor 
cells) can be accomplished by bringing the GNPs as close as possible to the target of the 
radiation, DNA.  It is also apparent that the radiobiological consequences of GNRT are 
most likely dependant on the GNP distribution and energy spectrum used to take 




MONTE CARLO STUDY OF CONE-BEAM POLYCHROMATIC XFCT 
 
 
3.1 - Introduction 
Tomographic reconstruction involves mathematically assembling a series of 1-
Dimensional images (or projections) to form a 2-Dimensional image.  This powerful tool 
allows one to examine the internal structure of an object without disturbing it.  However, 
for this type of imaging, the irradiation geometry and image reconstruction problem are 
very closely related. Depending on the application, many different configurations are 
possible.  X-Ray Fluorescence Computed Tomography (XFCT) is a stimulated emission 
tomography whereby the location and concentration of a high-Z substance is determined 
by measuring the signal of emitted fluorescence radiation.   
 
Synchrotron XFCT 
XFCT is traditionally performed using a pencil beam of monochromatic, synchrotron-
generated x-rays in order to generate an image of the distribution of some substance in a 
small object.52  The source spectrum is tailored to lie just above a photoelectric 
absorption edge of the element whose location inside the object is being interrogated to 
determine.  The emitted fluorescence photons are detected by an uncollimated detector 
which lies outside the object; thus, each data point consists of the response along the path 
of the pencil beam.  The beam (or object) is translated laterally so that the object is 
reasonably covered by these pencil beams, and this procedure is repeated as the object is 
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rotated.  This setup is shown in Figure 3.1.1.  The 1-D projections are formed for each 
projection angle by assembling the response of each pencil beam, and an image is 




Figure 3.1.1: Imaging geometry for synchrotron-based XFCT.  The fluorescence photons 
emitted by an object under irradiation by a monochromatic pencil beam are detected by 
an uncollimated detector.  The pencil beam is translated through the phantom, and this 
process is repeated as the phantom is rotated. 
 
The synchrotron-based approach to XFCT has several strengths.  The monochromatic 
source allows the fluorescence signal to easily be extracted from the scatter background, 
making it possible to image very small concentrations of high-Z substances such as 
iodine or gadolinium.  The resolution can be increased by using very small pencil beams.  
Also, the high dose rate source makes the time required for image acquisition small.  The 
drawbacks of this method include the prohibitively high cost and poor availability of 




An investigation was performed to determine the feasibility of using XFCT for human 
medical imaging, and the authors claimed that this technique would not be possible for 
large animals, given realistic constraints on dose and resolution.53  However, it was 
shown that Gold Nanoparticle (GNP)-based benchtop XFCT for a 5-cm-diameter object 
was possible with a polychromatic pencil-beam source.42  The image geometry was very 
similar to that shown in Figure 3.1.1; however, in order to deal with the increased 
Compton scatter due to the polychromatic source, the detector was collimated so as to 
have a restricted view within the phantom.  The image acquisition process was repeated 
for five different lateral translations of the detectors, and the projection data was 
constructed by summing the detector response along the line of each pencil beam.   
 
There are several problems with the polychromatic pencil beam XFCT scanning which 
make it impractical for in-vivo imaging.  The process of translating both the pencil beam 
and the detector made the scans extremely long (~50 hours) and the dose delivered very 
high (2 Gy). Also, while the back-projection-based image reconstruction method 
produced an accurate image of GNP concentration/location, the details of its 
implementation make it impractical for imaging under variable geometries.  Specifically, 
the attenuation correction was performed by manually calculating the path length of the 
pencil beam/fluorescence photons for each projection under conditions of known 
geometry.   
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The purpose of this Monte Carlo study was to optimize the image acquisition and 
reconstruction in order to improve image quality and decrease dose/scan time.  To that 
end, a cone-beam-based system was developed.  Under this imaging scenario, the entire 
phantom was irradiated by a broad beam of photons.  Instead of using a detector with a 
wide view within the phantom, the detector was collimated to have a narrow view.  Thus, 
spatial discrimination of the emitted fluorescence signal was not accomplished by 
restricting the size of the beam, but rather by the detector view.  This allowed for parallel 
data acquisition and removed the geometrical requirement of translating the pencil beam 
through the phantom, but increased the amount of noise due to Compton scatter. 
 
This study also sought to implement a better image reconstruction algorithm.  A 
Maximum Likelihood (ML-EM) iterative reconstruction algorithm54-56 was used, which 
allowed for better treatment of attenuation of both the primary beam and fluorescence 
photons.  This also allowed for the gold location/concentration determined in an iteration 
to be used to update the attenuation correction of the next iteration. 
 
3.2 - Monte Carlo Model 
Imaging Geometry 
 To simulate XFCT scanning of a small animal-sized object by the Monte Carlo (MC) 
method, MCNP557 calculations of polychromatic irradiation of a 5-cm-diameter 
polymethyl methacrylate (PMMA) phantom were performed. The general imaging 
geometry is shown in Figure 3.2.1A.  A cone beam of photons was incident on the 
phantom along the z-axis (or beam’s central axis).  The source of the cone beam was a 
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point source located 25 cm from the phantom.  The spectrum of these photons is shown 
in Figure 3.2.2, and was taken from measurements of a 110 kVp Hamamatsu Micro-
Focus X-ray source having been filtered by 680 m of lead.42  Note that, only photons 
above the K-edge of gold (80.7 keV) are able to create K-shell fluorescence, so the 
filtration is intended to reduce the fluence of photons below this level as they add only 
dose and noise.   
 
The phantom was composed of PMMA, and was 5 cm in both height and diameter.  The 
phantom contained several GNP-loaded regions, which were cylindrical in shape and 
ranged from 4 to 10 mm in diameter.  The GNP-loaded columns were 3 cm high, and sat 
2.5 cm deep in the phantom (leaving 0.5 cm extending from the top, as was the case in 
the pencil-beam XFCT study42).  These columns contained a mixture of GNPs and water, 
with a gold concentration ranging from 0.1% to 2.0% Au by weight (or 1 mg to 20 mg 
Au per g water).  These values were chosen to reflect possible concentrations of GNPs in 





(A)                                                                    (B) 
Figure 3.2.1: Schematic for Cone-beam Implementation of XFCT. (A) Geometry for 
Image Acquisition.  The phantom is rotated in steps of 6°, with a full scan being 
composed of either 30 projections (180°) or 60 projections (360°). (B) Offset detector 
configuration.  A second bank of detectors (Side B) is added to the opposite side of the 
phantom.  The dotted lines indicate the view of each detector behind the parallel-hole 









Data were acquired by a series of energy-sensitive tallies which are also shown in Figure 
3.2.1A.  They were positioned 1 mm behind a 4-cm-thick lead collimator with a series of 
parallel pinhole openings with a diameter of 2.5 mm. The phantom-to-collimator distance 
was 5 mm.  By virtue of the parallel-hole collimation, each detector had a view inside the 
phantom along the x-axis at an angle of 90° relative to the beam central axis.  Note that, 
in traditional synchrotron-based XFCT, spatial signal discrimination is accomplished by 
using a pencil beam, whereas in cone-beam XFCT spatial discrimination is accomplished 
using detector collimation.  Thus the reconstruction problem resembles Single Photon 
Emission Tomography (SPECT).  In order to improve detection efficiency and resolution 
while decreasing scanning time, a second set of detectors was added to the far side of the 
phantom.  This configuration is shown in Figure 3.2.1B.  Note that the second parallel-
hole collimator is offset from the first in order to decrease the effective pixel pitch and 
increase resolution.   
 
In order to simulate the XFCT scanning geometry, an independent simulation was 
performed for each projection angle. Additionally, an independent simulation was 
performed for each unique configuration of the imaging geometry, including varying the 
number of detectors (11, 17, or 25) or the position of the gold columns within the 
phantom.  Each detector in the imaging setup was represented as a deterministic point 
detector tally (F5) with an exclusion radius of 5 mm.  Each simulation was performed 





At gold concentrations on the order of 0-2% Au by weight, the spectrum of photons 
arriving at the detectors is dominated by Compton Scatter.  However, since Compton 
scatter creates a continuum of energies while atomic fluorescence occurs only at discrete 
energies, the gold fluorescence signal intensity can be extracted from the Compton 
background.  Due to the attenuation of low energy photons in the phantom, it was not 
practical to use the gold L-shell fluorescence (~10 keV) for image reconstruction.  The 
gold K lines (67.0 and 68.8 keV) are the best candidates for this type of imaging due to 
the decreased absorption at higher energies as well as the greater probability of K 
fluorescence emission compared to K fluorescence emission (~78 keV).   
 
 
Figure 3.2.3: Extracting Gold fluorescence signal from Compton background.  Solid line 
represents typical fluorescence spectrum when gold column containing 2% Au is in view 
of the detector.  The area covered by the dashed lines is the signal for a particular detector 
and angle.  (*) - 3rd degree polynomial fit of Compton background data.  (+) -  




A portion of a sample spectrum acquired from a detector during one projection is shown 
in Figure 3.2.3.  To extract the gold fluorescence peak height from the Compton 
background, a 3rd degree polynomial was fit to the points on either side of the gold 
fluorescence peaks.  The gold fluorescence signal intensity at that detector for that 
projection angle was then given by the difference of the measured signal and the 
polynomial fit.  By extracting the gold fluorescence signal intensity from each detector at 
each projection angle, a sinogram of the gold fluorescence signal intensity was 
constructed. More details about the gold fluorescence data acquisition and processing can 
be found elsewhere.42  
 
3.3 - Image Reconstruction  
Using the sinograms created during the data acquisition, an image of the gold distribution 
inside the phantom was reconstructed by applying a Maximum Likelihood (ML-EM) 
iterative reconstruction algorithm.54-56  Given the projection dataset p described by the 
measured sinograms, and some initial guess of the intensity in each pixel a, one must 
construct the matrix M, where each element Mi,j is the probability that a fluorescence 
photon will be created at the pixel ai and detected in the projection element pj.  This 
relationship is described in Eq. (3.3.1), and the operating equation for computing the next 





























1                                           (3.3.2) 
 
The construction of the attenuation matrix M was accomplished by considering four 
factors which influence the photon emission and detection probability: attenuation of the 
primary beam as it passes through the phantom, attenuation of emitted gold fluorescence 
photons by the phantom, attenuation of emitted gold fluorescence photons by other GNP-
loaded regions, and the 1/r2 dependence of the fluence of gold fluorescence photons from 
an isotropic source (i.e., GNP).   
 
Consider the geometry shown in Fig. 3.3.1.  To construct the attenuation matrix M, it is 
necessary to determine the probability that, for a beamlet entering the phantom at point 
A, a fluorescence photon will be emitted at point B and detected at point D. The 
attenuation of the primary beam as it travels from point A to B, P1, is given by Eq. 
(3.3.3). Also, the probability that the emitted fluorescence photon reaches the detector, 
P2, is given by Eq. (3.3.4). Note that the attenuation coefficient (r) is a function of 
position within the phantom in order to take into consideration changes in gold  
concentration along the intended path.  It also varies with energy and geometry; beam is 
given by broad beam attenuation of those source photons (~85 keV) which can cause 
gold K-shell fluorescence, while gold is given by narrow beam attenuation of gold K 
photons. Although each attenuation coefficient in this study was taken as a priori 
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knowledge, it can be determined during the realistic XFCT scanning by employing a 
transmission detector that produces an attenuation map of the imaged object. After each 
iteration of the reconstruction algorithm, the (r) value was updated for each point in the 
phantom by using the current map of the gold concentration.  This was used to update the 
attenuation matrix M. 
 
 
Figure 3.3.1: Geometry for Attenuation Correction.  It is necessary to determine the 
probability that, for an arbitrary point B within the phantom, a fluorescence event is 
induced by an external x-ray irradiation from the source (enetering the phantom at Point 
A), and the fluorescence photon reaches the detector (point D).  The complete attenuation 
correction matrix is constructed by iterating Eqs. (3) and (4) over all points (B) in the 
















                                                     (3.3.4) 
 
One well-known problem in iterative reconstruction for emission tomography is the 
tendency of image noise to increase if the number of iterations performed becomes large 
58.  For SPECT, it has been shown that the optimal solution for this problem is to apply a 
smoothing filter after each iteration to decrease noise.59  In the case of XFCT, an edge-
preserving Gaussian filter60 was applied. 
 
To test the performance of cone-beam XFCT scanning, images were reconstructed using 
MC data obtained under several different conditions. MC data were acquired with either a 
single bank of detectors on one side, or two banks of detectors on both sides (1-sided or 
2-sided scan).  The number of detectors in each bank was 11, 17, or 25.  60 projections 
covering the full 360° of phantom rotation were used during the MC data acquisition; 
however, by ignoring the latter 30 projections, an image can be reconstructed 
representing a 180° scan. Finally, these data were acquired for three different 
gold/phantom configurations.   
 
3.4 - Imaging Results and Imaging Metrics 
In order to make a comparison with the results of the existing bench-top pencil-beam 
XFCT scans,42 several scans under the current cone-beam geometry were simulated with 
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17 detectors in each bank.  The results of these scans for all three phantoms are shown in 
Fig. 3.4.1. The first phantom contained three GNP-loaded columns of diameter 1 cm, 
each at a constant radial position relative to the center of the phantom and with gold 
concentrations of 0.5, 1.0, and 2.0% Au by weight.  This phantom was very similar to the 
phantom used in previous pencil beam scanning, and showed similar results.  The gold 
concentration varied quite linearly with signal intensity. In the second phantom, five 
GNP-loaded columns of diameter 8 mm were placed in a line across the center of the 
phantom in order to test the attenuation corrections for both radial depth and increased 
self-absorption by GNP-loaded regions. This would constitute a “worst-case” scenario for 
the reconstruction of XFCT images. One can see that there was some blurring of the 
location of GNP-loaded regions, and the signal intensity was not as linear with gold 
concentration.  However, the lowest concentration (0.1% Au by weight) was still visible.  
In the third “spiral” phantom, eight gold columns of diameter 5mm ranging from 2.0% to 
0.25% Au by weight spiraled radially outwards from the center.  In this case, the GNP-
loaded locations were well-determined, and signal response was very linear.   
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Figure 3.4.1: Reconstructed images for the three phantoms considered.  Each phantom is 
labeled with the gold concentration (by weight) of each GNP-loaded column included.  
The right-side panels show the linear relationship between gold concentration and 
average signal intensity in each column. Results are shown for the XFCT setup with 360° 




In Fig. 3.4.2, the results of XFCT imaging using 11, 17, and 25 detectors are shown for 
the “spiral” phantom.  The resolution of the image increases with more detectors; 
however, there seems to be diminishing returns by using more than 17 detectors.  The 
distance between the two central columns (2% and 1.75%) is 1.3 mm, and it can be seen 
that those columns are resolved using 17 or more detectors.   
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Figure 3.4.2: Reconstructed images for spiral phantom (see also Fig. 3.3.1) with 11, 17, 
and 25 detectors. As the number of detectors increases, spatial resolution improves. 
Results are shown for the XFCT setup with 360° data acquisition, 2-sided. 
 
 
Fig. 3.4.3 compares the results of imaging the spiral phantom with limited information.  
Results are shown for scans using 25 detectors in each bank, and images are 
reconstructed using either one or both banks (one-sided or two-sided).  Additionally, 
results are shown for images reconstructed using 60 projections (360°) to 30 projections 
(180°).  Fig. 3.4.3(a) shows the relative error, which is defined as the sum of the squared 
difference of each pixel value in the image with the expected value. Fig. 3.4.3 (b) shows 
the coefficient of determination (R2) for the linear fit of the gold concentration measured 
in each column (see Fig. 3.4.1).  As expected, the image quality increases as more 
information is used in the reconstruction. The error decreases as the number of 
projections increase, and the calibration curve of gold concentration becomes much more 
accurate.  It can also be seen that the two-sided scans perform much better than one-
sided.   Reducing the number of projections to 30 would decrease the overall scan time 
and dose by a factor of two, but reducing the number of detector banks to one would 
decrease the overall cost of an eventual bench-top XFCT scanner.  Finally, it can be 
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noted that above 45 projections (270°), there seems to be diminishing returns in terms of 
image quality gained with increasing dose. 
 
Figure 3.4.3: Imaging metrics for the “spiral” phantom with 25 detectors.  Results are 
shown as the number of projections increases from 30 to 60, corresponding to 180°-360° 
imaging.  Panel (a) shows the relative error, which is defined as the sum of the squared 
difference of each pixel value in the image with the expected value.  Panel (b) shows the 




3.5 - Discussion 
The feasibility of a polychromatic cone-beam XFCT device described in this MC study 
may not be fully established without a successful demonstration by an experimental 
study. Nevertheless, the current MC results may provide valuable insight into possible 
design and technical specifications associated with such a device. According to the 
current results, a cone-beam implementation of polychromatic XFCT would result in a 
significant reduction of overall scanning time, compared to the pencil-beam 
implementation described in a previous study.42 It can be immediately noticeable there 
would be an almost 10 fold reduction in scanning time as a result of a cone-beam 
implementation, provided that the data acquisition time per projection during the cone-
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beam XFCT scanning remains the same as  that (i.e., 60 seconds) used during the 
previous pencil-beam work. This implies if the XFCT scanning of the phantom used in 
the pencil-beam study was repeated with the current cone-beam XFCT setup, the total 
scanning time could be less than an hour, which may be considered acceptable for in-vivo 
imaging.          
 
While the current MC results may provide an encouraging outlook for a drastic reduction 
of scanning time, it appears to remain as a technical challenge whether or not the 
detection limit for gold concentration could be lowered below 0.1% by weight or even 
more perhaps on the order of part per million. The current MC simulations in conjunction 
with deterministic tallies were believed to have yielded less noisy fluorescence signals 
than realistic experiments. Therefore, the detection limit shown in this study (i.e., 0.1% 
Au by weight) could be considered as the best theoretically possible value achievable 
from the current polychromatic cone-beam XFCT setup. Similar to previous arguments,42 
the detection limit might be reduced further by a few additional modifications to the 
current setup such as further tailoring/quasi-monochromatization of incident x-ray 
spectrum, use of novel fluorescence peak selection algorithm, and further optimization of 
detector collimation. These modifications would also help improve the resolution of 
XFCT images. Note the current MC results indicate an XFCT image resolution on the 
order of 1 mm could be achievable, which is comparable to or slightly better than that 








4.1 – Cone-beam Polychromatic XFCT - Experimental Setup and Image Acquisition 
Imaging Phantom and X-ray Beam 
In order to test a realistic small-animal XFCT scenario, samples containing gold 
nanoparticles (GNPs) were prepared which correlate with realistic tumor/blood gold 
concentrations achievable in vivo: namely, 2.0%, 1.0%, and 0.5% gold by weight.16  
Roughly cylindrical tubes of height 2 cm and diameter 6 mm were filled with saline 
solution, and commercially available GNPs of diameter 1.9 mm (Aurovist™, Nanoprobes 
Inc) were added.  In total, the tubes contained 6.5 mg, 3.3 mg, and 1.6 mg of GNPs, 
respectively.  The GNP-loaded tubes were then inserted into a cylindrical phantom 3 cm 
in diameter and 5 cm in height.  The phantom was composed of polymethyl methacrylate 
(PMMA).  The three tubes were located 9 mm from the center of the phantom, and 
spaced at 120º intervals.  This geometry is shown in Figure 4.1.1. 
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(a)                                                                            (b) 
Figure 4.1.1: Imaging Phantom.  The PMMA phantom is shown from the side (a) and top 
(b). 
 
To acquire images of the GNP location/concentration, the phantom was irradiated with a 
110 kVp microfocus x-ray source (L9631, Hamamatsu Photonics, Inc) operating at 400 
A.  The source had a focal spot size less than 100 m and an emission angle of 62º.  The 
beam was collimated by a conical hole through a lead block 5 cm thick.  The angle of the 
conical hole was 11.4º, with front/back hole diameters of 1 and 2 cm.  The center of the 
phantom was roughly 8 cm from the collimator surface (14.5 cm from exit window of 
source), yielding a beam whose diameter just exceeded the 3 cm phantom diameter.   
 
Although the nominal maximum tube voltage was 110 kVp, the x-ray tube was operated 
at 105 kVp in order to increase beam stability over the entire course of the irradiation.  
The beam was filtered by 1.0 mm of lead, yielding the beam spectrum shown in Figure 
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4.1.2.  The filter thickness must be chosen carefully in order to a) reduce image dose, b) 
maximize photon fraction over the K-edge of gold (80.7 keV), and c) retain as much 








Figure 4.1.3: Image Acquisition Geometry.  In order to simulate data acquisition by a 
serial CdTe detector behind a parallel-hole collimator, the single detectors were translated 
along the z-axis. 
 
Image Acquisition 
The imaging geometry is shown in Figure 4.1.3.  Gold K-shell fluorescence photons were 
acquired by two identical thermoelectrically cooled cadmium telluride (CdTe) 
photodiode detectors (XR-100 T-CdTe, Amptek Inc).  A digital pulse processor and 
multichannel analyzer (PX4, Amptek Inc) interfaced between the detectors and a personal 
computer, which collected, stored, and analyzed the results.  Since the measured 
spectrum of photons emitted from the phantom was overwhelmingly dominated by 
Compton scatter (see Figure 3.1.3), it was essential to restrict the view of the detector 
within the phantom as tightly as possible.  Thus, each detector sat behind a 4-cm-thick 
lead pinhole collimated with a hole diameter of 2.5 mm.   
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The view of each detector was along the x-axis, at a 90º angle to the central axis of the 
beam (z-axis).  The system remained stationary for the acquisition of each projection, 
which lasted 1-5 minutes.  After this, the phantom was rotation about its central axis by 
6º, and this process was repeated for 60 projections, corresponding to 360º coverage of 
the phantom.   In order to simulate an 11-pixel serial detector, each CdTe detector was 
translated along the z-axis after the completion of a full 360º rotation.  The detector 
positions were 3 mm apart, and these 11 positions spanned the entire length of the 
phantom.  In order to increase the data collection rate, as well as the spatial resolution, 
the detectors were slightly offset.  For each phantom rotation, the view of the two 
detectors was offset 1.5 mm apart along the z-axis. 
 
Data were acquired as a series of five sets of 60 projections (each one minute long), 
allowing the reconstruction of images using one, two, three, four, or five minutes per 
projection.  In order to correct for differences in detection efficiency between the two 
CdTe detectors used, the spectra of total counts from one detector were normalized to 
have the same overall count rate as the other detector.  For each detector position and 
projection angle, the gold fluorescence peak height was extracted from the Compton 
scatter background using the method described in Section 3.2, and these signals were 
assembled to form a sinogram of gold fluorescence signal with respect to position and 
angle.  The reconstruction of the images was also accomplished using the same procedure 
as described in Section 3.2, which used a maximum-likelihood (ML-EM) iterative 
algorithm which corrected for the effects of attenuation in both the primary beam and 
emitted fluorescence photons.   
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4.2 - XFCT Sinograms and Reconstructed Images 
It was necessary to normalize the magnitude of the spectra received by the two CdTe 
detectors, owing to the differences in response between them.  This was done by 
equalizing the total sum of the detector response at each position.  Ideally, this effect of 
detector response would be built into the attenuation matrix M (see Eq. 3.2.1) through 
standardized measurements with a constant source.  However, the method used was 
adequate for these purposes. 
 
The measured sinograms and reconstructed images for 360º acquisition are shown in 
Figure 4.2.1.  Measurements were taken as a series of five 1-minute-projection 
acquisitions, allowing the reconstruction of images using one, two, three, four, or five 
minutes per projection.  One can see that, as the amount of data collected increases, the 
image quality improves.  In the 1-minute image, only the 2% column is well defined, and 
there is excessive noise throughout the image.  At 3 minute per projection, all three 
columns are well defined and the noise is only a slight problem.  There appear to be 
diminishing returns past 3 minutes per projection.  The right column in Figure 4.2.1 
shows the relationship between signal intensity in the reconstructed image and gold 
concentration.  The goodness of fit (R2) value for the 5 minute image is 0.93.  The only 
significant change in this curve as more dose is given is to bring the intensity down for 
pixels that should not have any fluorescence signal. 
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Figure 4.2.1: Reconstructed images of the 3-cm-diameter phantom for data acquisition 
using 1-5 minutes of scanning time per projection.  Each phantom is labeled with the gold 
concentration (by weight) of each GNP-loaded column included.  The right-side panels 
show the linear relationship between gold concentration and average signal intensity in 
each column. Results are shown for the XFCT setup with 360° data acquisition. 
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Figure 4.2.2 shows the results of several imaging metrics for images reconstructed using 
varying amount of information.  The Image Error Factor is a function of the differences 
between the reconstructed and expected pixel value at each point in the image.  For pixels 
within the GNP-loaded regions, the error is simply the square of the difference between 
actual and expected values.  For pixels outside the GNP-loaded regions, the expected 
value is zero, and the sum of the squared differences is generally small compared to that 
of the GNP-loaded regions.  However, these false-positive signals severely degrade the 
quality of the image.  Therefore, for these pixels, the error factor is multiplied by a scalar 
factor to make the magnitude of the false-positive error comparable to that of the GNP-
loaded regions. Data are shown for images reconstructed using only data from detectors 
on one side of the phantom as well as images using both detectors.  Images are 
reconstructed using 30, 45, or 60 projections (180º, 270º, and 360º, respectively), 
corresponding to 50%, 75%, or 100% of the maximum imaging dose per projection.  As 
expected, the image error decreases in all cases as more dose per projection is used.  One 
can also see that, in general, the image quality improves as two detectors are used instead 
of one, and also as more projections (and therefore dose) are used. 
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Figure 4.2.2: Image Error Factor for images reconstructed using varying amounts of 
information.  As the error factor decreases, image quality improves.  The dashed lines 
represent images reconstructed using only data from detectors on one side of the 
phantom, while the solid lines are those images using both detectors.  Images are 
reconstructed using 30, 45, or 60 projections (180º, 270º, and 360º, respectively), 
corresponding to 50%, 75%, or 100% of the maximum imaging dose per projection. 
 
4.3 - XFCT Imaging of Larger Phantom 
The primary obstacle to a successful implementation of XFCT is the amount of Compton 
scatter which occurs within the phantom.  Therefore, a larger object is more difficult to 
image with a cone beam as there is more scatter which drowns out the gold fluorescence 
signal.  Early testing of cone beam XFCT was done using the same experimental setup as 
the pencil beam scanning: namely, a 5-cm-diameter phantom irradiated by a 110 kVp 
source filtered with 0.68 mm lead.  It was seen that, using this configuration, it was 
difficult to image the regions loaded with GNPs at 1% by weight or lower.  Once the 
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Figure 4.3.1: 5-cm-diamter phantom for XFCT imaging. 
 
The 5-cm phantom was imaged using the same procedure described in Section 4.1.  Note 
that, instead of the prior GNP-column configuration (3 columns 120º apart), the 5-cm 
phantom contains 4 holes for GNP-loaded tubes.  For this image, three of the columns 
were filled with tubes containing water and GNPs at 2%, 1%, and 0.5% by weight.  The 
tubes were 1 cm in diameter, and 3.5 cm in height.  They sat in the phantom at a depth of 
2.5 cm, with 0.5 cm extending above the top.  The fourth hole was filled with a PMMA 
plug.  The only difference in imaging setup was that the phantom center was 22.9 cm 
from the source exit window, in order for the beam to cover the entire phantom.  This 
resulted in a lower dose rate than in the 3-cm phantom case (see Section 4.4).  The image 




The results of the 5-cm phantom XFCT are shown in Figure 4.3.2.  All data are shown for 
sinograms and images reconstructed using 60 projections per scan at an interval of 6º, 
resulting in 360º coverage of the phantom.  The time per projection varied from 1 to 5 
minutes.  Several points are notable from this figure.  First, it was possible to distinguish 
all three gold columns (2%, 1%, and 0.5% by weight).  Second, the imaging results are 
very noisy, even at 5 minutes per projection.  This is due to both the increased phantom 
size (increasing Compton scatter and decreasing signal-to-noise ratio) and decreased dose 
rate of the source at this distance.  However, it can be seen that the 5 minute image in the 
5-cm phantom is roughly equivalent to the 3 minute image in the 3-cm phantom in terms 




Figure 4.3.2: Reconstructed images of the 5-cm-diameter phantom for data acquisition 
using 1-5 minutes of scanning time per projection.  Each phantom is labeled with the gold 
concentration (by weight) of each GNP-loaded column included.  The right-side panels 
show the linear relationship between gold concentration and average signal intensity in 
each column. Results are shown for the XFCT setup with 360° data acquisition. 
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4.4 - Dose Measurements for XFCT Imaging Procedures 
In order to measure the x-ray dose delivered during XFCT scanning, ion chamber 
measurements were performed using a standard Farmer-type ionization chamber (PTW 
N30013).  The PMMA dose phantom, shown in Figure 4.4.1, consisted of a central 3-cm-
diameter base and a 1-cm-thick cylindrical sleeve, which when placed onto the base 
makes a 5-cm-diameter cylindrical phantom.  This allowed for dose measurements to be 
performed for both the 3-cm and 5-cm diameter phantoms.  The phantom contained holes 
matching the shape of the ion chamber spaced roughly 1 cm apart.  For each 
measurement, the chamber was placed into one of the phantom holes, and the others were 
filled with PMMA plugs whose shape matched that of the hole. 
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Figure 4.4.1: Dose Phantom for Ion Chamber Measurements.  The dose phantom consists 
of a central 3-cm-diameter PMMA base and a 1-cm-thick cylindrical sleeve, which when 
placed onto the base makes a 5-cm-diameter cylindrical phantom.  The phantom contains 
holes matching the shape of a PTW N300001 Farmer chamber spaced roughly 1 cm 
apart. 
 
The dose measurement geometry was identical to the irradiation geometries used in 
Sections 4.4.2-3.  The center of the 3-cm phantom was placed 14.5 cm from the beam 
exit window, while the 5-cm phantom (3-cm base with 1-cm-thick sleeve) was centered 
at 22.9 cm from the exit window.  In both cases, the x-ray beam used matched the beam 




Dose calibration was performed according to the AAPM TG-61 protocol,61  using the 
aforementioned Farmer-type chamber connected to an electrometer (Max 4000, Standard 
Imaging, Inc).  There were some deviations from this procedure: namely, calibration was 
performed in-phantom rather than in water, and the field size was the same as that used 
for imaging rather than 10x10 cm2.  The first problem was taken into account through the 
attenuation ratio (en/) for PMMA and air, and the second factor lead to some 
uncertainties (~1%) in the chamber correction factor PQ,chamb, which was deemed 
acceptable within the scope of current study. The half-value layer (HVL) of the beam was 
measured to be 12 mm Al. This value is generally found in diagnostic beams > 150 kVp; 
however, the heavy filtration used (1.0 mm Pb) significantly hardens the beam.  Because 
of this, the attenuation ratios (en/) for PMMA, air, and water were calculated explicitly 
using the measured spectrum in Figure 4.1.2.   
 
Using this procedure, the dose rate was measured at the center of the phantom.  For the 3-
cm phantom, the dose rate was 0.17 cGy/min; for the 5-cm phantom, 0.092 cGy/min.  
The differences were due to both the increased size of the 5-cm phantom as well as the 
closer source-to-phantom center distance of the 3-cm phantom (14.5 cm vs. 22.9 cm).  
Dose was also measured at several points throughout the phantom.  From these data, 
percent depth-dose and dose profile curves were constructed.  These are shown in Figure 
4.4.2.  Additionally, it was measured that the dose rate for a full revolution of the 
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(a)                                                                  (b) 
Figure 4.4.2: Dose profile (a) and percent depth-dose (b) for the 3-cm and 5-cm 
phantoms.  Dose profiles are measured at a depth equivalent to the center of the phantom.   
 
 
4.5 - MicroCT of GNP-loaded Phantom 
In order to compare the performance of XFCT to existing imaging modalities, a Micro 
Computed Tomography (MicroCT) scan of the XFCT phantom was performed.  The 
image was performed on the 3-cm phantom (see Section 4.1).  The phantom contained 
three GNP-loaded tubes, which contained a mixture of water and GNPs at 2%, 1%, and 
0.5% by weight. The image was acquired using a commercial MicroCT scanner 
(SCANCO Medical) operating at 90 kVp filtered by 0.1 mm of aluminum.  512 
projections were acquired with an integration time of 300 ms.  The results of this scan are 




Figure 4.5.1: MicroCT of GNP-loaded phantom.  The 3-cm-diameter contained three 
tubes with a mixture of water and GNPs.  The concentration (weight %) of GNPs in each 
tube is denoted in the figure. 
 
In Figure 4.5.1, it can be seen that there is a large amount of contrast in the case of the 
2% tube, allowing one to discern its location.  There is a significant decrease in contrast 
for the 1% and 0.5% tubes.  It may be possible to distinguish these concentrations of 
GNPs in an otherwise perfectly homogeneous phantom, but in a realistic small-animal 
scenario, one would expect heterogeneities such as bone, lung, or other organs to make 
the small Hounsfield unit (HU) change due to GNPs indistinguishable.  However, XFCT 
is acquired at a 90º angle with respect to the beam axis, and does not interfere with a 
normal transmission image.  Consider the hypothetical fusion image shown in Figure 
4.5.2.  This image was formed by scaling/rotating the MicroCT and XFCT results by 
hand in order to align the relevant structures.  It is possible that XFCT and MicroCT 
images could be acquired simultaneously using a single piece of equipment.  Similar to 
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PET/CT, these two modalities are complimentary, with one providing anatomical 
information and the other providing functional information. 
 
 
Figure 4.5.2: Fusion Image between MicroCT and XFCT. 
 
One would also expect that XFCT would outperform MicroCT in delineating the location 
of GNPs in a heterogeneous geometry.  Consider the geometry in Figure 4.5.3.  This is a 
hypothetical MicroCT image of a phantom containing three GNP-loaded regions and 
three high-density regions such as bone.  In this case, based on material density alone, 
MicroCT may not be able to distinguish between the two.  However, by augmenting the 





Figure 4.5.3: Hypothetical MicroCT/XFCT image of a digitally fabricated phantom 
containing three GNP-loaded regions and three high-density or “bone” regions.  The left 
image shows the expected result of MicroCT scanning, and one cannot distinguish GNP-
loaded regions from bones based solely on material density.  The right panel shows a 
hypothetical CT/XFCT fusion image, allowing one to distinguish the two different 
regions. 
 
4.6 - Monochromatization of Polychromatic X-Ray Source 
The data collected during XFCT scanning are overwhelmingly dominated by Compton 
scatter, with a signal-to-noise ratio (SNR) of 1/100 to 1/1000.  The quality of the 
reconstructed image can be significantly improved if advances can be made in reducing 
the amount of scattered photons.  This makes it especially important to take great care in 
determining the spectrum of source photons used for XFCT.  Ideally, the beam spectrum 
would be such that the gold fluorescence peaks and the Compton scatter spectrum of the 
beam are at different energies; however, due to the physics of x-ray generation and the 
limitation that the beam must be at least 80.7 keV to trigger gold K-shell fluorescence, 
this becomes difficult to accomplish realistically.  Synchrotron facilities can produce very 
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bright monochromatic beams, but it is challenging to monochromatize a polychromatic 
broad-beam spectrum from a traditional x-ray tube.  
 
Recently, efforts have been made to monochromatize a polychromatic broad-beam 
spectrum using Bragg Diffraction in a medium with sufficiently small lattice spacing, 
such as highly-oriented pyrolitic graphite (HOPG).  This technology has been applied to 
radiation-based imaging and therapy,62-63 and efforts were made to adapt this approach to 
GNP-based XFCT in the current study.  Bragg Diffraction is governed by the relationship 
in Eq. 4.6.1, where the lattice spacing d and the angle of incidence  define the 
wavelength  that is coherently scattered out of the lattice.   
 
 nd sin2                                                                     Eq. 4.6.1 
 
By depositing a thin film of HOPG (d = 335.4 pm) onto a properly curved surface, 
powerful manipulations of the x-ray spectrum are possible.64  The goal in the case of 
XFCT is to scatter the beam in such a way as to create a source spectrum that, when 
scattered into the detector, does not significantly interfere with the gold fluorescence 
photons.  To accomplish this, MCNP557 simulations were performed in which a PMMA 
phantom was irradiated by various quasi-monochromatic x-ray spectra.  The phantom 
contained a region loaded with GNPs at 2% by weight, and the spectrum of photons 
emitted from the phantom was collected by an energy-sensitive volumetric (F4) tally 
placed at a 90º angle relative to the beam central axis, whose geometry mimicked a 
commercial CdTe detector.   Quasi-monochromatic spectra were used due to the slight 
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angular spread of materials such as HOPG, causing the reflected spectrum to contain 
some deviation in energy.  The results of these simulations are shown in Figure 4.6.1 for 
quasi-monochromatic sources of average energy 85, 90, and 95 keV, each with a full-
width half-maximum (FWHM) of 5 keV.  It is apparent that a source energy of at least 95 
keV must be used for quasi-monochromatic XFCT at a 90º detection angle, otherwise the 
Compton scatter obscures the resultant gold fluorescence peaks.  From Eq. 4.6.1, the 95 
keV photons could be extracted from a polychromatic beam if it was incident onto a layer 
of HOPG at an angle of n*1.1º (n = 1, 2, 3 …). 
 
 
Figure 4.6.1: Spectrum of gold fluorescence and Compton scattered photons from quasi-
monochromatic x-ray source spectra (FWHM 5 keV).  At least 95 keV is required for a 
clear view of gold K peaks. 
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Unfortunately, this extremely small scattering angle makes this application difficult for 
benchtop, cone-beam use.  Even if the n=5 angle of 5.5º was used (which would require 
filtration of the lower energy multiples of ), a configuration capable of creating a quasi-
monochromatic broad beam is challenging to envision.  Figure 4.0.2 shows the shape of 
an HOPG layer required to reflect the rays of a cone beam at 5.5º.  The cone beam enters 
the frame from the left side, and the HOPG layer is represented as a roughly parabolic 
black line.  The color of the lines show the path of each ray as it reflects from the HOPG 
layer.  Photons in the cone beam which do not match the energy of the required Bragg 
diffraction angle would interact with the HOPG layer normally. 
 
 
Figure 4.6.2: Monochromatic reflection of a cone-beam source with a thin HOPG film.  
A cone beam (source located at x=y=0, not shown) is reflected with HOPG at 5.5º, 
causing 5th-order Bragg diffraction of 95 keV photons.  The curved HOPG surface 
required is 1 cm long and roughly 1 mm tall. 
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This low scattering angle geometry makes monochromatization difficult for many 
reasons.  First, any slight change in angle has a very large effect on the scattered energy.  
For instance, at 1.1º, an increase of 0.5º corresponds to an energy of 65 keV (Eq. 4.6.1).  
Effects such as the intrinsic mosaic spread of HOPG and the x-ray spot size would 
increase the uncertainty in scattering angle.  Secondly, in order to have any impact on the 
beam spectrum, one must separate the scattered photons from the primary beam.  This 
could most easily be accomplished by constructing a cylindrical HOPG scatterer with an 
attenuator such as lead in the center.  However, for the geometry in Fig. 4.6.2, this 
cylinder would have an inner radius of approximately 1 mm, and would utilize a very 
small fraction of the x-ray beam resulting in a low imaging dose rate. 
 
On the other hand, there is no doubt that this method holds great promise for improving 
GNP-based XFCT.  Figure 4.6.3 shows the spectrum of photons diffracted from a small 
layer HOPG.  A 1x1 cm2 piece of commercially available HOPG (1.2 mm thick, mosaic 
spread 1º, NT-MDT Co.) was placed in a pencil beam of 110 kVp photons 1.5 mm in 
diameter. A CdTe detector was placed just laterally outside the primary beam at a 
distance of 50 cm from the HOPG crystal.  The detector was collimated by a 2x2x4 cm3 
lead pinhole collimator with a hole diameter of 2.5 mm.  While the measured spectrum is 
far from ideal, including a large variance in the peak energy spread as well as Compton 
scattered photons, it demonstrates that, with a more careful approach to the HOPG 





Figure 4.6.3: Spectrum of 110 kVp x-rays measured after small-angle reflection from a 
thin 1x1 cm2 HOPG crystal. 
 
4.7 Discussion 
This study demonstrates the feasibility of imaging GNP location and concentration within 
3-5 cm objects using an ordinary polychromatic x-ray source.  Several molecular imaging 
applications of this technology are discernable.  A recent study used conjugated quantum 
dots (QDs)27 for molecular imaging of tumors in vivo.   Another study26 demonstrated the 
feasibility of targeting tumors using bio-conjugated GNPs. While optical imaging 
techniques can be used to image QDs in vivo, no current imaging modality can image 
GNPs in vivo.  With some refinements to detection limit and scan time, it would 
eventually be possible to generate both 2D and 3D tomographic images of an animal 
injected with conjugated or unconjugated GNPs using XFCT.   
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It was found that the dose rate during imaging for the 3 and 5 cm phantoms was 0.17 
cGy/min and 0.092 cGy/min, respectively.  Thus, for the images described above 
containing 60 projections and 11 detector positions, the total dose delivered to the 3 and 5 
cm phantoms was 5.7 Gy and 3.0 Gy, respectively.  However, the cone-beam irradiation 
geometry allows for simultaneous data collection using multiple detectors, so the total 
dose could be reduced by a factor of 11 if a single-line CdTe array detector were used.  A 
similar type of detector has been used for other similar imaging modalities, such as K-
edge imaging.41   
 
Table 4.7.1: Dose (cGy) required in the 3 and 5 cm phantoms for XFCT images acquired 
using 1-5 minutes per projection, with 30, 45, or 60 projections per image.  This table 
assumes that an array detector is used. 
Projections per Image, 5 cm Projections per Image, 3 cm Projection 
Time (min) 30 45 60 30 45 60 
1 2.8 4.1 5.5 5.2 7.9 10.5 
2 5.5 8.3 11.0 10.5 15.7 21.0 
3 8.3 12.4 16.6 15.7 23.6 31.5 
4 11.0 16.6 22.1 21.0 31.5 42.0 
5 13.8 20.7 27.6 26.2 39.3 52.5 
 
Table 4.7.1 shows the dose required to image the two phantoms using an array detector   
It was seen in Sections 4.3 and 4.4 that a sufficient image was generated with 60 
projections using 3 min/projection in the 3 cm phantom, and 5 min/projection in the 5 cm 
phantom.  Therefore, the dose required for XFCT imaging using the current methodology 
is roughly 30 cGy.  This is much less than the general LD50 (50% Lethal Dose) for mice 
of about 7 Gy,65 and possibly less than typical ranges of x-ray doses delivered during 
micro-CT scanning of small animals.66-69  These are encouraging results, as they suggest 
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that XFCT is currently feasible with realistic constraints on the amount of x-ray dose 
delivered.    
 
With an array detector, the scan time required could also be brought within acceptable 
limits.  For a 60 projection scan, the time required for the 3 and 5 cm phantoms would be 
3 and 5 hours, respectively.  This could be further reduced by using a higher dose-rate 
source, or by improving image acquisition to require either less projections or less time 
per projection.  It is also possible that the amount of data required to reconstruct an 
acceptable image could be reduced by using a more sophisticated gold fluorescence peak 
extraction algorithm, or by using a detector with a higher energy resolution at the 
energies considered (65-70 keV). With the implementation of all or part of these for the 
current XFCT setup, the scan time acceptable for routine in-vivo imaging work (~ < 1 







It has been shown that, by taking advantage of the high atomic number of gold (Z=79), 
several interesting applications for photon-based therapy and imaging are possible.  The 
significant increase in photoelectric interaction probability for gold allows it to be used as 
a contrast agent, both in terms of increasing dose deposited during radiotherapy as well as 
allowing differentiation between gold-loaded and normal tissue during photon imaging.  
If gold nanoparticles (GNPs) can be preferentially targeted to tumor tissue, this allows 
one to selectively escalate dose to tumor tissue while sparing normal tissue from harm.  If 
GNPs can be preferentially targeted to any structure (including tumors), this also allows 
one to generate a tomographic image of GNP location and concentration and, based on 
the results of this imaging, derive biological information about either the nature of the 
target of GNPs or the nature of the agents used to target them. 
 
This study presents a nanometer-scale calculation framework which computes the energy 
spectrum of secondary electrons emitted during gold nanoparticle-aided Radiation 
Therapy (GNRT), the point dose kernels of these spectra, and the microscopic dose 
enhancement resulting from the addition of GNPs to tumors under realistic treatment 
scenarios.  The results presented for dose enhancement during GNRT agree with the 
results of several other studies, including measurements of dose behind a gold foil,51 
theoretical calculations of GNP dose enhancement for vascular disruption,70 and Monte 
83 
Carlo calculations of photon interaction enhancement in GNPs of various sizes.50  The 
central theme of the GNRT-related results is that extreme dose enhancement can be 
achieved within very short (< 5 m) distances from GNPs.  Given the short ranges of 
secondary electrons from GNPs, it can be expected that the maximum radiobiological 
benefit (killing of tumor cells) can be accomplished by bringing the GNPs as close as 
possible to the target of the radiation, DNA.  It is also apparent that the radiobiological 
consequences of GNRT are most likely dependant on the GNP distribution and energy 
spectrum used to take advantage of the enhanced photoelectric cross section. 
 
This study also presents a potential benchtop molecular imaging modality for 
determining the location and concentration of high-Z materials in small animal-sized 
objects.  The modality is based on the detection of K-shell fluorescence photons emitted 
by GNP-loaded regions in an object undergoing irradiation by a filtered cone beam of 
diagnostic polychromatic x-rays.  The methods of data acquisition, fluorescence 
extraction from background, and image reconstruction were tested using Monte Carlo 
methods.  The location and concentration of GNPs within a PMMA phantom was 
determined, and a lower limit of detection using this methodology was established at 
roughly 0.1% gold by weight.  These methods were then applied to acquire images of 
GNP-loaded columns within PMMA phantoms of diameters 3 and 5 cm.  The use of a 
cone beam image acquisition geometry allowed these images to be obtained under 
realistic constraints on dose, scan time, and resolution.   
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There are many avenues for improving upon the results of this work.  The ultimate goal 
of this investigation is to apply the currently developed techniques to various pre-clinical 
studies with small animals.  While it is difficult to experimentally verify dose delivered 
on such a small scale, the dose enhancement results presented here suggest a significant 
enhancement in the radiobiological consequences of radiation therapy by using GNPs; 
specifically, they predict an increase in the local dose deposited which would lead to an 
increase in tumor cell killing.   
 
Since the results can be computed on extremely small (i.e. 1 nm) scales, the 
computational model presented here could be expanded to include calculating the dose 
directly to DNA or other cellular structures, given that the GNPs could be localized and 
imaged in a reasonable way.  Since the size of the target of radiation damage (i.e. DNA) 
is roughly 2 nm in diameter, the dose enhancement results presented here could become 
part of a broader calculation framework which would use theoretical models to predict 
the number of single-strand/double-strand DNA breaks.  Future targeting methods for 
GNPs could be evaluated based on a calculated cell survival fraction, and these results 
could be tested in in vitro dose enhancement studies. This would allow the formation of a 
calculation framework which could predict more accurately the radiobiological outcomes 
of GNRT. 
 
There are also many feasible ways to improve imaging with XFCT.  The most obvious 
improvement to the current XFCT setup would be the utilization of a CdTe array-based 
detection system that is able to record line integrals through the phantom in parallel 
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during cone-beam irradiation.  This would immediately reduce scan time and dose by a 
factor of 11 or more, depending on the detector configuration.  Moreover, since the 
measured signal is overwhelmingly dominated by Compton scatter and the primary 
impediments to image quality are the fluctuations in this scatter background, the best way 
to improve image quality is to reduce the amount of scatter.  This could be accomplished 
using some novel configuration of HOPG which would create a bright, cone-beam, 
monochromatic source at 95 keV, which would significantly reduce the amount of 
Compton scatter detected at the energies of gold K fluorescence.  Additionally, the 
results could be improved using a more sophisticated beam filter, such as one comprised 
of a tin/copper/aluminum mixture.  Barring this, the signal could conceivably also be 
improved if some novel/sophisticated peak extraction algorithm were able to more easily 
discern gold fluorescence peaks from the Compton background.  This would allow a 
reduction in x-ray dose delivered, or a decrease in the scan time required for image 
acquisition.  This may also allow XFCT imaging of lower concentrations of GNPs or of 
larger objects. 
 
XFCT is distinct in that it is a truly molecular imaging modality.  Rather than detecting 
some property of a medium or an agent/molecule, XFCT is capable, in theory, of 
identifying any element within an object by observing its characteristic fluorescence.  For 
a high-atomic-number agent, such as a GNP, it has been shown possible to image realistic 
concentrations (0.7 wt% Au) in a mouse-sized object.  This technique could be used to 
facilitate small-animal studies for GNRT, and combined with the dose enhancement 
calculations presented herein could comprise a framework whereby the measured 
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concentrations of GNPs in a mouse tumor could be used to calculate the enhancement in 
photon dose during x-ray therapy.  These results could be tested against the 
radiobiological outcomes of that therapy.  XFCT could also facilitate small animal 
studies with any agent capable of functionalization with a GNP.  For instance, if a novel 
drug or other therapeutic agent were attached to a GNP, XFCT could be used to measure 






SPECTRUM OF SECONDARY ELECTRONS 
 
 
A.1 - Spectrum of Secondary Electrons during GNRT 
The secondary electron spectra from atoms of gold approximating GNPs and molecules 
of water during photon irradiation of a GNP-loaded tumor were obtained using the 
EGSnrc code system,71 which was used to record the number and energies of electrons 
created through the photoelectric, Compton, and atomic relaxation processes. A total of 
six photon source spectra were considered: 125I, 103Pd, 169Yb, 192Ir, 50 kVp x-rays, and 6 
MV x-rays.  For the current investigation, water, instead of tissue, was chosen as the base 
material for the phantom and tumor, since the electron track structure code used for dose 
calculations is currently only capable of handling electron transport in water. For the 
brachytherapy sources (i.e., all sources apart from 6 MV), the dimensions of the phantom 
and tumor were 30 x 30 x 30 cm3 and 3 x 3 x 3 cm3, respectively. The tumor composed of 
either water or water loaded with gold at 7 mg Au/g was located centrally within the 
phantom and contained a source isotropically emitting photons at its center. In the case of 
the 6 MV x-ray source, the phantom geometry was altered to reflect external beam 
delivery rather than brachytherapy. Specifically, a 4 x4 cm2 6 MV beam  was incident 
normally onto the surface of a 30x30x30 cm3 water phantom at 100 cm source-to-surface 
distance (SSD).  The tumor was a 2x2x3 cm3 region at 5-8 cm depth in the phantom 
along the central axis of the beam, and was composed of either water or water loaded 
with 7mg Au/g. 
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The six photon source spectra were chosen in an attempt to replicate realistic treatment 
scenarios.  For 125I, 103Pd, and 169Yb, measured spectra of physical brachytherapy seeds or 
sources were used.22, 72-73  For 192Ir, the spectrum of a microSelectron HDR source 
included in the EGSnrc code package was used. The 6 MV beam spectrum was obtained 
from a previous study on Varian 2100 series accelerators.74 The 50 kVp source was 
intended to represent various miniature x-ray delivery devices,75-77 but the spectrum used 
was that of a generic beam with 1.5 mm Al filter and 17 W target78 independent of a 
particular make/model of miniature x-ray device.  The cutoff energy for these simulations 
was 1 keV for both photon and electrons. 
 
The secondary electron spectra for gold and water resulting from these photon 
irradiations are shown in Figures A.1-A.6. Here, the secondary electron spectra for gold 
are presented combined with the spectra for water to show the magnitude of the increase 
in secondary electron production caused by the presence of gold.  On the other hand, 
during the current simulations for the dose point kernels, separate secondary electron 
spectra for gold atoms and water molecules were used. 
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Figure A.1: Secondary Electron Spectra for 50 kVp X-ray Source 
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Figure A.3: Secondary Electron Spectra for 103Pd Source 
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Figure A.5: Secondary Electron Spectra for 192Ir Source 
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Figure A.6: Secondary Electron Spectra for 6 MV X-ray Source 
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APPENDIX B 
MICROSCOPIC DOSE ENHANCEMENT 
 
 
To calculate the microscopic dose enhancement due to the presence of gold, the kernels 
were applied to a scanning electron microscopy (SEM) image of a GNP distribution in 
tissue.30 Using the methods described in Section 2.4, each pixel in the image was treated 
as a point source of either gold or water secondary electrons based on the intensity of that 
pixel, and with the dose point kernels, the radial dose distribution around each pixel was 
calculated. The microscopic dose enhancement due to GNPs in the sample SEM image, 
defined as the ratio of dose deposited at each point between the gold and water cases, is 






Figure B.1: Microscopic Dose Enhancement from 125I photon source for the specific GNP 
distribution in vivo obtained from the previous work.32 1.05, 1.10, and 2 represent 5%, 





Figure B.2: Microscopic Dose Enhancement from 103Pd photon source for the specific 
GNP distribution in vivo obtained from the previous work.32 
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Figure B.1: Microscopic Dose Enhancement from 192Ir photon source for the specific 




Figure B.1: Microscopic Dose Enhancement from 6 MV photon source for the specific 
GNP distribution in vivo obtained from the previous work.32 
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APPENDIX C 
SAMPLE INPUT CODES 
 










using namespace std; 
using std::cout; 
 
const double pi = 3.14159265; 
 
double norec_source(double *, float *, int, RandomNumber &); 
//samples the source spectrum 
 
void isotropic(double &, double &, double &, RandomNumber &); 
//isotropically generates a direction vector 
 
volatile int ctrlc_pressed = 0; 
void ctrlc_handler ( int sig ) { 




int main(int argc, char *argv[]) 
{ 
  long int time1=time(0), time2; 
  double timer; 
  RandomNumber ran; 
  ran.setSeed((unsigned)time(0)); 
  int k, j, N, nps, rbin; 
  double *E, energy=0; 
  float *prob; 
  double u=0,v=0,w=1; 
  double r_max; 
 
  int Nbins; 
  long double * dose; 
  long int * hits; 
  char fn[80], fn2[80]; 
  ifstream spec, inp; 
  ofstream output; 
 
  signal( SIGINT, ctrlc_handler ); 
 
  if (argc != 2) 
  { 
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    cout << "NOREC <filename>\n"; 
    return 0; 
  } 
  inp.open(argv[1], ios::in); //open the input file 
   
  //read the name of the input spectrum filename and open it 
  inp >> fn; 
  spec.open(fn, ios::in); 
  inp >> fn; 
   
  inp >> nps;  //number of particles to simulate 
  inp >> Nbins; //total number of dose bins 
  inp >> r_max; //maximum radius to transport particles to 
  if (!(spec.is_open() )) 
  { 
    cout << "Problem with filenames " << argv[1] << ' ' << argv[2] << 
'\n'; 
    return 0; 
  } 
  dose = new long double [Nbins]; //energy deposition in each bin 
  hits=new long int [Nbins]; //number of deposition events in each bin 
   
   
  //initialize energy deposition to zero 
  for (k=0; k<Nbins; k++) 
  { 
    dose[k]=0; 
    hits[k]=0; 
  } 
 
   
 
 
  cout << "\n\n----------------------------------------------------" << 
'\n'; 
  cout << "Running NOREC for spectrum in file " << argv[1] << '\n'; 
  cout << "----------------------------------------------------" << 
'\n'; 
  cout << "Number of Histories to run: " << nps << '\n' << '\n'; 
   
 
  /////////////////////// 
  //READ INPUT SPECTRUM// 
  /////////////////////// 
  spec >> N; 
    E = new double [N]; 
    prob = new float [N]; 
  for (k=0; k<N; ++k) 
    spec >> E[k] >> prob[k]; 
 
  //normalize probabilities 
  double max=0; 
  for (k=0; k<N; ++k) 
    if (prob[k] > max) 
      max=prob[k]; 
  for (k=0; k<N; ++k) 
    prob[k]/=max; 
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  ///////////////////////////// 
  //BEGIN MAIN TRANSPORT LOOP// 
  ///////////////////////////// 
   
    Track t; 
  double x, y, z, r; 
  for (k=0; k<nps; ++k) 
  { 
    if (k==nps/100) 
    { 
      time2=time(0); 
      timer=time2-time1; 
      cout << (double(nps)-k)*timer/3600/k << " hours remain\n"; 
    } 
    if (k%(nps/10)==0) 
    { 
      cout << "Particle #" << k << '\n'; 
      if (k) 
      { 
        for (j=0; fn[j]!='\0';j++) 
          fn2[j]=fn[j]; 
        fn2[j]='0'+10*k/nps; 
        fn2[j+1]='\0'; 
        output.open(fn2, ios::out); 
        output << "R(um)\tDose(eV)\tError(%)\n"; 
        for (j=1; j<Nbins; ++j) 
          output << (j)*r_max/Nbins << '\t' << dose[j]/nps << "\t\t" << 
100/sqrt(float(hits[j])) << '\n'; 
        output.close(); 
      } 
    } 
 
 
    //isotropically generate a direction vector 
    isotropic(u,v,w,ran); 
 
 
    //allow user to pause simulation to check progress 
    if (ctrlc_pressed) 
    { 
      cout << "--------------------------------------------------------
-\n"; 
      cout << "INTERRUPT at particle " << k << '\n'; 
      time2=time(0); 
      timer=time2-time1; 
      int status_input = 1; 
      while (status_input) 
      { 
        cout << "d: Dump dose information to file\n"; 
        cout << "q: Dump dose information to file and exit\n"; 
        cout << "Q: Exit without saving\n"; 
        cout << "c: Continue running\n"; 
        cout << (double(nps)-k)*timer/3600/k << " hours remain\n"; 
         
        char status; 
98 
        cin >> status; 
        if (status == 'd' || status == 'q') 
        { 
          status_input = 0; 
          output.open(fn, ios::out); 
          output << "R(um)\tDose(eV)\tError(%)\n"; 
          for (j=1; j<Nbins; ++j) 
            output << (j)*r_max/Nbins << '\t' << dose[j]/k << "\t\t" << 
100/sqrt(float(hits[j])) << '\n'; 
          if (status == 'q') 
            return 0; 
          output.close(); 
        } 
        else if (status == 'Q') 
          return 0; 
        else if (status == 'c') 
          status_input = 0; 
      } 
 
      ctrlc_pressed=0; 
      signal( SIGINT, ctrlc_handler ); 
      cout << "--------------------------------------------------------
-\n\n"; 
    } 
     
 
    //sample from the energy spectrum until a result < 1MeV is obtained 
    do  
      energy=1000000*norec_source(E, prob, N, ran); //energy in eV 
    while (energy > 1000000); 
     
    t.generateTrack(energy,0,0,0,u,v,w); //generate particle 
    int escape = 0; 
 
    //transport particle until it falls below energy threshold or 
escapes 
    while(!t.isOver() && !escape) 
    { 
      t.getLine(&x,&y,&z,&energy);  //determine location and energy of 
next event 
      r=sqrt(pow(x,2)+pow(y,2)+pow(z,2)); //calculate radial position 
       
      //if particle is within geometry, deposit its energy in the 
appropriate bin 
      if (r<r_max) 
      { 
        rbin = ceil(r/r_max*Nbins); 
        dose[rbin] += energy; 
        hits[rbin]++; 
      } 
      else 
        escape=1; 
    } 
  } 
 
  //output results and clean up memory 
  output.open(fn, ios::out); 
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  output << "R(um)\tDose(eV)\tError(%)\n"; 
  for (k=1; k<Nbins; ++k) 
    output << (k)*r_max/Nbins << '\t' << dose[k]/nps << "\t\t" << 
100/sqrt(float(hits[k])) << '\n'; 
 
  spec.close(); 
  output.close(); 
  inp.close(); 
  delete E, prob, dose, hits; 
 
  time2=time(0); 
  timer=time2-time1; 
  cout << '\n' << nps << " particles in " << timer/3600 << " hours\n"; 
  cout << nps/timer*3600 << " particles per hour\n"; 
 




double norec_source(double * E, float * prob, int N, RandomNumber &r) 
{ 
/*  E - energy bins 
  E[0] = energy lower bound - below this bin prob = 0 
  prob[0] = 0 
*/ 
 
  int finished = 0, bin; 
  double lower, upper; 
   
  bin = floor(r.ran2()*N); 
  while (r.ran2() > prob[bin]) 
    bin = floor(r.ran2()*N); 
 
  upper = E[bin]; 
  lower = E[bin-1]; 
 
  return (r.ran2()*(upper-lower)+lower); 
} 
 
void isotropic(double &u, double &v, double &w, RandomNumber &r) 
{ 
  double phi, theta; 
 
  phi = pi*r.ran2(); 
  theta = 2*pi*(r.ran2()-1); 
 
  u = sin(phi)*cos(theta); 
  v = sin(phi)*sin(theta); 
  w = cos(phi); 
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